发明名称 |
Aripiprazole formulations having increased injection speeds |
摘要 |
The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates. |
申请公布号 |
US9526726(B2) |
申请公布日期 |
2016.12.27 |
申请号 |
US201615164473 |
申请日期 |
2016.05.25 |
申请人 |
ALKERMES PHARMA IRELAND LIMITED |
发明人 |
Hickey Magali B.;Vandiver Jennifer |
分类号 |
A61K31/497;A61K31/496;A61K9/00;A61K47/26 |
主分类号 |
A61K31/497 |
代理机构 |
Lathrop & Gage LLP |
代理人 |
Lathrop & Gage LLP ;Trinque Brian C. |
主权项 |
1. A kit for the treatment of schizophrenia, wherein the kit comprises a therapeutically effective amount of a pharmaceutical composition and further comprises instructions for intramuscular injection, wherein the instructions specify a continuous intramuscular injection within 10 seconds, wherein said pharmaceutical composition comprises:
(a) 24-30 weight percent Compound 1: (b) 0.3-0.4 weight percent sorbitan laurate; (c) 0.1-0.3 weight percent polysorbate 20; and (d) an aqueous vehicle wherein the percentages of (a), (b), and (c) are relative to the total weight of the composition; wherein the pharmaceutical composition has a total injection volume of approximately 3.2 mL. |
地址 |
Dublin IE |